Skip to content

Clinical trials

Phase 1 Dementia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 1 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20044
20062
20071
20082
20101
20112
20121
20131
20142
20162
20173
20197
20213
20223
20231
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting5
Terminated3
Unknown status3
Not yet recruiting2
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)3
National Institute of Neurological Disorders and Stroke (NINDS)3
Texas Christian University3
University of Kansas Medical Center3
Eli Lilly and Company2
Stanford University2
Tetra Discovery Partners2
Abrexa Pharmaceuticals, Inc.1
Allyx Therapeutics1
Alzheimer's Disease Expert Lab (ADEL), Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia48
Alzheimer Disease26
Cognitive Dysfunction15
Neurodegenerative Diseases6
Brain Diseases4
Central Nervous System Diseases4
Mental Disorders4
Nervous System Diseases3
Neurocognitive Disorders3
Parkinson Disease3

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.